Clinical Trials Logo

Clinical Trial Summary

This pioneering prospective observational study aims to examine biopsychosocial and neuropsychological functioning, care needs and predictors of therapeutic adherence in children/adolescents in pre/post-surgical transplant (solid organ or allogeneic haematopoietic stem cell) phases. Hypothesis: H1. Differences in biopsychosocial and neuropsychological functioning and adherence will be observed between transplant types; H2. Executive functioning will mediate the relationship between anxiety, sleep disturbance and pain intensity/interference and adherence; H3. There will be a significant improvement in different neuropsychological indicators 6 months post-transplantation. Sample: patients (8-18 years) extracted by non-probabilistic sampling, estimating a sample size of 60 patients (30 for each type of transplant, organ and haematopoietic) from Hospital Universitario La Paz (Madrid). Individual pre/post-surgical assessments will be carried out (after 2 and 4 weeks), as well as at 6 months post-transplant, both in person (neurocognitive) and through the secure platform REDCap (completed by patients and their legal guardians). Finally, focus groups will be conducted among patients, their relatives and medical-surgical professionals to identify barriers to therapeutic adherence and unmet care needs during the pre-, peri- and post-surgical process.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05441436
Study type Observational
Source Hospital Universitario La Paz
Contact Eduardo Fernández-Jiménez, PhD
Phone +34630305521498401
Email eduferjim.psyc@gmail.com
Status Recruiting
Phase
Start date May 26, 2022
Completion date May 26, 2025

See also
  Status Clinical Trial Phase
Completed NCT04985409 - Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant N/A
Recruiting NCT05798286 - Quantra® System With the QPlus® Cartridge in Double-lung Transplantation N/A
Terminated NCT02434146 - Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy Phase 1/Phase 2
Withdrawn NCT03399227 - Liver Transplantation: Skeletal Effects
Recruiting NCT05967130 - Treatment Chronic UTI Post Kidney Transplant Phase 3
Recruiting NCT05600855 - Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model Phase 2
Recruiting NCT05599256 - Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model Phase 2
Completed NCT03811873 - Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates N/A
Completed NCT05629923 - EVALUATION OF DIFFERENT PROPHYLACTIC INTERVENTIONS TOWARD COVID-19 IN SOLID ORGAN TRANSPLANT PATIENTS
Completed NCT03448679 - Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT N/A
Active, not recruiting NCT03769441 - Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation Phase 3
Active, not recruiting NCT03636412 - Improving Frailty With a Rigorous Ambulation Intervention in Lung Transplant Patients N/A
Recruiting NCT06066957 - Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients Phase 2
Recruiting NCT03015012 - Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial) N/A
Not yet recruiting NCT06208137 - Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution. N/A
Not yet recruiting NCT04756622 - N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. Phase 3
Available NCT06393660 - Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)